S.Biomedics Co., Ltd. (KOSDAQ:304360)
27,800
-1,050 (-3.64%)
At close: May 20, 2026
S.Biomedics Revenue
In the year 2025, S.Biomedics had annual revenue of 16.55B KRW with 20.49% growth. S.Biomedics had revenue of 4.03B in the quarter ending December 31, 2025, a decrease of -9.35%.
Revenue
16.55B
Revenue Growth
+20.49%
P/S Ratio
20.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
344.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.55B | 2.81B | 20.49% |
| Dec 31, 2024 | 13.73B | 625.65M | 4.77% |
| Dec 31, 2023 | 13.11B | 995.73M | 8.22% |
| Dec 31, 2022 | 12.11B | 3.24B | 36.58% |
| Dec 31, 2021 | 8.87B | 3.55B | 66.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LS SECURITIES | 2.09T |
| CYMECHS | 164.40B |
| Global Tax Free | 154.06B |
| Exicon | 66.03B |
| Wooriro | 42.47B |
| ASTERASYS Co.,Ltd | 37.94B |
| Ecoeye | 30.92B |
| FutureChem Co.,Ltd | 18.67B |